RENEE HALL: Open Payments
NPI 1316671217 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 11 payments from 9 companies in 2025. Trend: 2023 $523 · 2024 $771 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 2 | $117 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $105 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Baxter Healthcare | 1 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Corium, LLC | 1 | $9 |
Products named: FANAPT, AUSTEDO XR, Auvelity, INGREZZA, COBENFY, FLOSEAL, REJOYN, LYBALVI.
Industry payments across TN — which companies pay providers there.
